Alpha-emitting nanoparticles and the Warburg Effect, skin diseases, eating disorders, musculoskeletal disorders, alcoholism, cigarette, hypersexuality and neurofibromatosis type 1


Alpha-emitting nanoparticles and the Warburg Effect, skin diseases, eating disorders, musculoskeletal disorders, alcoholism, cigarette, hypersexuality and neurofibromatosis type 1


Florent Pirot

Independent researcher


Alpha emitting nanoparticulates in internal contamination, an IARC Class 1 carcinogen, have an extremely wide list of effects. New effects are here demonstrated based on a wide epidemiological survey. WHO data in particular is used together with other large sets and juxtaposed to known sources of variations of radioactivity contamination in the environment to demonstrate the link which is always explained by the strong decay energy and its impact on the organism. Some behaviours are shown to be strategies of pain reduction, others of decontamination. This article confirms the simple logic of biophysics (the linear-no-threshold model) outlined by the author in previous publications.


Keywords: Alpha-emitting nanoparticles; the Warburg Effect; skin diseases; eating disorders; musculoskeletal disorders; alcoholism; cigarette; hypersexuality; Multiple sclerosis; rheumatoid arthritis; neurofibromatosis

Free Full-text PDF


How to cite this article:
Florent Pirot. Alpha-emitting nanoparticles and the Warburg Effect, skin diseases, eating disorders, musculoskeletal disorders, alcoholism, cigarette, hypersexuality and neurofibromatosis type 1. Research Journal of Pharmacology and Pharmacy, 2021; 5:11. DOI: 10.28933/rjpp-2021-06-0505


REFERENCES

First part:
1. Iyer R, Lehnert, BE, Svensson R. Factors underlying the Cell Growth-related Bystander Responses to α Particles, Cancer Research 2000;60:1290-8
2. Lacerda F, Pinheiro PS, Cabral JM, Câmara JG, Rodrigues VL. Cancer in the Azores: initial results from a recently established population-based cancer registry, Revista Brasileira de Epidemiologia, vol.15 no.2, 2012, doi: 10.1590/S1415-790X2012000200006
3. Pirot F, Alpha emitting nanoparticulates, the forgotten pollutant, in From an Einstein Syndrome to the People, Editions universitaires européennes, 2019
Second part:
1. Miller AC, Rivas R, Tesoro L, Kovalenko G, Kovaric N, Pavlovic P, Brenner D. Radiation exposure from depleted uranium: The radiation bystander effect. Toxicology and Applied Pharmacology. 2017 Sep 15;331:135-141. doi: 10.1016/j.taap.2017.06.004.
2. Pirot F. Traumatic Brain Injury: a Case Report and Its Contribution to Understanding the Underlying Mechanisms – Alpha-Emitting Nanoparticulates Proven as Key. American Journal of Medical Case Reports. Vol. 8, No. 4, 2020, pp 100-102. http://pubs.sciepub.com/ajmcr/8/4/2, doi: 10.12691/ajmcr-8-4-2
3. Wheeler BW, Allen J, Depledge MH, Curnow A, 2012, Radon and skin cancer in southwest England: an ecologic study. Epidemiology doi: 10.1097/EDE.0b013e31823b6139
4. Braüner EV, Loft S, Sørensen M, Jensen A, Andersen CE, Ulbak K, Hertel O, Pedersen C, Tjønneland A, Krüger Kjær S, Raaschou-Nielsen O, Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort. 2015, PloS One, doi: 10.1371/journal.pone.0135642
5. Vienneau D, de Hoogh K, Hauri D, Vicedo-Cabrera AM, Schindler C, Huss A, Röösli M, SNC Study Group, Effects of Radon and UV Exposure on Skin Cancer Mortality in Switzerland. 2017, Environmental Health Perspectives, doi: 10.1289/EHP825.
6. Wade BJ, Spatial Analysis of Global Prevalence of Multiple Sclerosis Suggests Need for an Updated Prevalence Scale, 2014, Multiple Sclerosis International, doi: 10.1155/2014/124578 Pirot F. The link between salt and neurological disorders, the mediation of alpha-emitting nanoparticulates as simple explanation, Porto Biomed J, 2019; 4(6), doi: 10.1097/j.pbj.000000000 0000055
Third part:
1. Boström AE, Chatzittofis A, Ciuculete DM, Flanagan JN, Krattinger R, Bandstein M, Mwinyi J, Kullak-Ublick GA, Görts Öberg K, Arver S, Schiöth HB & Jokinen J, Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes, Epigenetics, 2019, doi:10.1080/ 15592294.2019.1656157
2. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D’Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 2012-11-01, doi:10.1038/nature11582
3. McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagacé C, Li C, Green T, Stevens CR, Beauchamp C, Fleshner PR, Carlson M, D’Amato M, Halfvarson J, Hibberd ML, Lördal M, Padyukov L, Andriulli A, Colombo E, Latiano A, Palmieri O, Bernard EJ, Deslandres C, Hommes DW, de Jong DJ, Stokkers PC, Weersma RK, NIDDK IBD Genetics Consortium, Sharma Y, Silverberg MS, Cho JH, Wu J, Roeder K, Brant SR, Schumm LP, Duerr RH, Dubinsky MC, Glazer NL, Haritunians T, Ippoliti A, Melmed GY, Siscovick DS, Vasiliauskas EA, Targan SR, Annese V, Wijmenga C, Pettersson S, Rotter JI, Xavier RJ, Daly MJ, Rioux JD, Seielstad M, Genome-wide association identifies multiple ulcerative colitis susceptibility loci, Nature Genetics, 2010-03-14, doi: 10.1038/ng.549
4. Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lémann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panés J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nature Genetics, 2011-02-06, doi: 10.1038/ng.764
5. De Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, Jostins L, Rice DL, Gutierrez-Achury J, Ji SG, Heap G, Nimmo ER, Edwards C, Henderson P, Mowat C, Sanderson J, Satsangi J, Simmons A, Wilson DC, Tremelling M, Hart A, Mathew CG, Newman WG, Parkes M, Lees CW, Uhlig H, Hawkey C, Prescott NJ, Ahmad T, Mansfield JC, Anderson CA, Barrett JC, Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease, Nature Genetics, 2017-01-09, doi: 10.1038/ng.3760
6. Corvol H, Blackman SM, Boëlle PY, Gallins PJ, Pace RG, Stonebraker JR, Accurso FJ, Clement A, Collaco JM, Dang H, Dang AT, Franca A, Gong J, Guillot L, Keenan K, Li W, Lin F, Patrone MV, Raraigh KS, Sun L, Zhou YH, O’Neal WK, Sontag MK, Levy H, Durie PR, Rommens JM, Drumm ML, Wright FA, Strug LJ, Cutting GR, Knowles MR, Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis, Nature Communications, 2015-09-29, doi: 10.1038/ncomms 9382
7. Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G,Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, International Multiple Sclerosis Genetics Consortium, International IBD Genetics Consortium, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK, Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations, Nature Genetics, 2015-07-20, doi: 10.1038/ng.3359
8. Sallaberry CA, Astern L, The Endocannabinoid System, our Universal Regulator, Journal of Young Investigators 2018-06-01
9. US Veterans‘ Administration, newspiece by Mike Richman, https://www.research.va.gov/currents/0617-study_yields_insight_on_sexual_disorder.cfm 2017-06-07
10. Bolt MA, Helming LM, Tintle NL, The Associations between Self-Reported Exposure to the Chernobyl Nuclear Disaster Zone and Mental Health Disorders in Ukraine, Frontiers in Psychiatry, 2018-02-15, doi: 10.3389/fpsyt.2018.00032
Fourth part:
1. Tsirikos AI, Saifuddin A, Noordeen MH. Spinal deformity in neurofibromatosis type-1: diagnosis and treatment, Eur Spine J. 2005 Jun; 14(5): 427–439. doi: 10.1007/s00586-004-0829-7
2. Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations, Int J Clin Exp Pathol. 2012; 5(9): 852–862.
3. van Minkelen R, van Bever Y, Kromosoeto JN, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85(4):318–327. doi:10.1111/cge.12187
4. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010; 152A:327–332. doi: 10.1002/ajmg.a.33139.
5. Pasmant E, Vidaud D. Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View, EbioMedicine (The Lancet), April 30, 2016, doi:10.1016/j.ebiom.2016.04.036
6. Leppävirta J, Epidemiology of neurofibromatosis type 1 in Finland: Incidence, mortality, pregnancies and congenital malformations, Annales Universitatis Turkuensis, MedicaOdontologica, Turku, Finland, 2018
7. Yanfang X, Chiamvimonvat N, Vázquez AE, Akunuru S, Ratner N, and Yamoah EN. Gene-Targeted Deletion of Neurofibromin Enhances the Expression of a Transient Outward K+ Current in Schwann Cells: A Protein Kinase A-Mediated Mechanism, J Neurosci. 2002 Nov 1; 22(21): 9194–9202. doi: 10.1523/JNEUROSCI.22-21-09194.2002
8. Fieber LA, González DM, Wallace MR, Muir D. Delayed rectifier K currents in NF1 Schwann cells. Pharmacological block inhibits proliferation. Neurobiol Dis. 2003 Jul;13(2):136-46. doi: 10.1016/s0969-9961(03)00031-7
9. Coleman BG, Arger PH, Dalinka MK, Obringer AC, Raney BR, Meadows AT. CT of sarcomatous degeneration in neurofibromatosis. Am J of Roentgenology. 1983;140(2):383–387. doi: 10. 2214/ajr.140.2.383
10. Avery RA, Mansoor A, Idrees R, Trimboli-Heidler C, Ishikawa H, Packer RJ, Linguraru MG. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1. Neurology. 2016 Dec 6;87(23):2403-2407. doi: 10.1212/WNL.0000000000003402
11. Drucker NA, Blaibel MF, Nagaraju S, Wang SK, Goggins W, Fajardo A. Renal Autotransplant and Celiac Artery Bypass for Aneurysmal Degeneration Related to Neurofibromatosis Type 1. Vasc Endovascular Surg. 2019 Aug;53(6):497-500. Doi: 10.1177/1538574419846711
12. Strowd RE 3rd, Rodriguez FJ, McLendon RE, Vredenburgh JJ, Chance AB, Jallo G, Olivi A, Ahn ES, Blakeley JO. Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1. Am J Med Genet A. 2016 Jun;170(6):1455-61. doi: 10.1002/ajmg.a.37622
13. Billiet T, Mädler B, D’Arco F, Peeters R, Deprez S, Plasschaert E, Leemans A, Zhang H, den Bergh BV, Vandenbulcke M, Legius E, Sunaert S, Emsell L. Characterizing the microstructural basis of “unidentified bright objects” in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis. Neuroimage Clin. 2014 Apr 13;4:649-58. doi: 10.1016/j.nicl.2014.04.005
14. Tucker T, Schnabel C, Hartmann M, Friedrich RE, Frieling I, Kruse HP, Mautner VF, Friedman JM.Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet. 2009 Apr;46(4):259-65. doi: 10.1136/jmg.2008. 061895.
15. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF. Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment, Science, 2002, 296(5569), doi: 10.1126/science.1068452
16. Fletcher JS, Pundavela J, Ratner N. After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation, Neuro-Oncology Advances, vdz045, doi:10.1093/noajnl/vdz045
17. Pirot F. Alpha-Emitting Nanoparticulates and Their Various Physical Effects: More Case Studies in Laboratory Research and History. Applied Mathematics and Physics. Vol. 8, No. 1, 2020, pp 1-7. http://pubs.sciepub.com/amp/8/1/1, doi: 10.12691/amp-8-1-1
18. Esposito T, Schettino C, Polverino P, Allocca S, Adelfi L, D’Amico A, Capaldo G, Varriale B, Di Salle A, Peluso G, Sorrentino G, Lus G, Sampaolo S, Di Iorio G, Melone MAB. Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients, Nutrients 2017 Jul; 9(7): 783. doi: 10.3390/ nu9070783
19. Pirot F, The shuriken effect of fertile alpha emitters : a physical process behind findings of chemical toxicity of depleted uranium. International Journal of Nanoparticle Research, 2021; 4:15. DOI: 10.28933/ijonr-2021-03-1303